GOODWILL AND INTANGIBLE ASSETS-NET (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Intangible Asset, Indefinite-Lived [Line Items] | ||||||
| Goodwill | $ 31,835,000 | $ 31,835,000 | $ 31,442,000 | $ 19,186,000 | ||
| Amortization expense | 3,000,000.0 | $ 2,800,000 | $ 6,300,000 | $ 5,600,000 | ||
| Weighted-average amortization period | 2 years | |||||
| Medical Practice Management Segment [Member] | ||||||
| Intangible Asset, Indefinite-Lived [Line Items] | ||||||
| Goodwill | $ 90,000 | $ 90,000 | $ 90,000 | |||
| X | ||||||||||
- Definition Weighted-average period of amortization for finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|